With global growth signals mixed, inflation still in focus, and energy costs and tariffs keeping markets on edge, more investors are looking beyond the mega caps for the next wave of AI-driven growth. The AI Small Caps screener is designed to surface earlier stage companies using machine learning, automation, or data intelligence in ways that could benefit from these cross currents, such as shifting demand patterns and changing cost pressures. In this article, you will see three of the most notable stocks from the screener, along with clear, practical context to help you judge whether they belong on your watchlist.
Overview: ImExHS (ASX:IME) provides cloud based medical imaging software and outsourced radiology services, helping hospitals and clinics manage radiology, cardiology and pathology imaging and reporting. Its key platforms, including AQUILA, ALULA and ANTEROS, support both image storage and clinical workflows across multiple countries from a base in Sydney.
Operations: ImExHS generates about A$10.0 million from Software and A$19.2 million from Radiology, with almost all of its roughly A$29.0 million in revenue coming from Latin America.
Market Cap: A$16.5 million
ImExHS stands out in the AI Small Caps screener because it links cloud native imaging software with its own radiology operations, giving it real world data and workflows to refine AI tools and potentially improve margins over time. The business is still loss making with weaker Return on Equity and relies heavily on Latin American health systems, so delayed payments or policy shifts could affect cash flow quality. With a low P/S ratio against peers and a new CFO with deep regional experience stepping in, the key question is how these pieces translate into long term value for shareholders.
ImExHS combines cloud imaging, real world radiology data and a low P/S, but the real story sits in how that mix could reshape its earnings profile. Get the full picture in the analysis report for ImExHS
Overview: Pureprofile (ASX:PPL) is a data and insights company that runs online research and survey platforms, helping brands, agencies and researchers understand consumer behaviour and run targeted campaigns across Australasia, Europe and the United States.
Operations: Pureprofile generates about A$61.3 million in Data & Insights revenue, with roughly A$34.6 million from Australasia, A$14.4 million from the United States and A$12.3 million from Europe.
Market Cap: A$39.7 million
Pureprofile catches the eye in the AI Small Caps screener because its entire business revolves around turning large volumes of consumer and behavioural data into actionable insights, an area where AI tools can materially change efficiency and value. The company is already profitable with a 3.1% net margin and a high return on equity around 20%, and analysts expect earnings growth of 36.43% per year. However, funding risk is higher because all liabilities come from external borrowing and the board currently has no independent directors. For investors who can look past these governance and funding concerns, the mix of growth expectations, data assets and current pricing raises the question of what the market might be missing.
Pureprofile’s 36.43% earnings growth outlook, current profitability and 20% return on equity suggest the story may be bigger than its market cap implies, but the real kicker sits inside the analyst forecasts for Pureprofile
Overview: Data#3 (ASX:DTL) is an Australian IT solutions provider that helps organisations in sectors like healthcare, education and government move to the cloud, secure their systems, manage devices and tap into data and AI to run more efficiently.
Operations: Data#3 generates about A$551.4 million from Infrastructure Solutions, A$262.2 million from Services, A$70.7 million from Software Solutions and A$0.3 million from Unallocated Other.
Market Cap: A$1.5b
Data#3 attracts attention in the AI Small Caps screener because it sits at the heart of multiyear trends such as cloud migration, device refresh cycles, security spending and AI deployment. It also maintains very high current and forecast return on equity near 58%. At the same time, heavy reliance on vendors such as Microsoft, pressure on channel incentives, competition from global providers and public sector insourcing reduce how predictable that growth is. For investors, the key consideration is how to weigh premium pricing, moderate forecast earnings growth and funding risks against the pull of recurring revenue, cybersecurity demand and the company’s record of quality earnings and fully franked dividends.
Data#3’s premium pricing and strong 58% return on equity suggest the market may be missing something about its quality and earnings power, and the full picture only really comes into focus in the 3 key rewards and 2 important warning signs (1 is major!)
The three stocks you have just seen are only a starting point, and the full AI Small Caps screener surfaces 4 more AI focused small caps with equally compelling narratives that do not fit into a single article. Use Simply Wall St to identify, filter and analyze the exact catalysts and storylines that matter to you so you can focus on the highest conviction AI small cap opportunities.
If Data#3 or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.
Momentum can shift quickly, and the strongest breakouts often move before the crowd catches on. Scan fresh, under the radar ideas while it matters, then act now.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com